key: cord-0779817-dql6c0jq authors: Wong, Julius; Layton, Daniel; Wheatley, Adam K.; Kent, Stephen J. title: Improving immunological insights into the ferret model of human viral infectious disease date: 2019-10-03 journal: Influenza Other Respir Viruses DOI: 10.1111/irv.12687 sha: 4a57f2f528842aa5dc0fd95788f524bc9b4b03bd doc_id: 779817 cord_uid: dql6c0jq Ferrets are a well‐established model for studying both the pathogenesis and transmission of human respiratory viruses and evaluation of antiviral vaccines. Advanced immunological studies would add substantial value to the ferret models of disease but are hindered by the low number of ferret‐reactive reagents available for flow cytometry and immunohistochemistry. Nevertheless, progress has been made to understand immune responses in the ferret model with a limited set of ferret‐specific reagents and assays. This review examines current immunological insights gained from the ferret model across relevant human respiratory diseases, with a focus on influenza viruses. We highlight key knowledge gaps that need to be bridged to advance the utility of ferrets for immunological studies. Ferrets can be directly infected with influenza from human clinical isolates without prior adaptation. Influenza infection of ferrets recapitulates key hallmarks of human clinical disease, such as high fever accompanied by sweating, as well as respiratory symptoms such as rhinorrhea and sternutation. 35 , 36 The shared susceptibility to influenza infection is based on similarity in respiratory tract physiology, where a predominance of α2,6-linked sialic acid (SA) receptors in the upper respiratory tract of ferrets mimics that of humans, 37-41 unlike α2,3-SA prevalent in other species such as mice. Ferrets are an extremely valuable model for studies on influenza pathogenesis 42, 43 and both direct and aerosol transmission. 44, 45 Critically, ferrets are a susceptible host for highly pathogenic avian strains of influenza with pandemic potential, such as H5N1 and H7N9, although disease severity in infected ferrets is somewhat variable. 42, [46] [47] [48] Similar variability in pathogenesis has been reported for some seasonal strains such as recent H3N2 isolates, 49, 50 which display a range of disease severity in humans 51 but generally remain mild in ferrets. 52, 53 Ferrets play a critical role in annual seasonal influenza vaccine strain selection. Antigenic drift in circulating strains is monitored primarily using hemagglutination inhibition (HI) assays on serum from ferrets infected with recently circulating human viral isolates. 54, 55 In both ferrets and humans, HI titres are a marker of protection from acquiring infection and currently the key immunological correlate for assessing potential vaccine effectiveness. Currently licensed seasonal vaccines, historically trivalent (TIV) but increasingly quadrivalent inactivated vaccines (QIV), can protect both ferrets 56, 57 and humans 58, 59 from infection and disease. Protection is mediated through neutralising antibodies targeting a cluster of epitopes surrounding the viral receptor-binding domain (RBD) within the highly variable hemagglutinin (HA) head domain (HA1). 60, 61 Inactivated influenza vaccines significantly reduce mortality rates in children 62, 63 and severe disease in adults. 58, 64 However, vaccine protection is notoriously strain-specific, and mismatches between vaccine and circulating strains through antigenic drift lead to low vaccine efficacy. [65] [66] [67] There are global efforts to increase the breadth of protection of influenza vaccines, with an eventual goal of universal protection (reviewed in 68 ) , and most strategies have been evaluated in ferret models. A non-exhaustive list of strategies to induce heterosubtypic immunity against influenza evaluated in ferrets include: HA stem vaccination [69] [70] [71] ; prime-boost with chimeric HA-based vaccines 72 ; use of conserved influenza proteins such as nucleoprotein (NP), [73] [74] [75] matrix-1 (M1), 74,76 matrix-2 (M2) 75, 77 and RNA polymerase subunit B1 (PB1) 74 ; replication-deficient viruses [78] [79] [80] [81] ; live attenuated formulations [82] [83] [84] ; the use of potent adjuvants such as Protollin, 85 glucopyranosyl lipid adjuvant-aqueous formulation (GLA-AF), 86 CoVaccine HT, 87 cationic adjuvant formulation 88 and poly-g-glutamic/chitosan nanogel 89 ; Escherichia coli-derived vaccines 90 ; DNA, mRNA and viral vector vaccines 75, [91] [92] [93] ; and the use of virus-like particles (VLP). 76 Additional examples of important ferret studies include (but are not limited to) evaluating the influence of changing the route of influenza inoculation on subsequent immunity 94 and the use of neuraminidase (NA) inhibitors as prophylaxis. 95 The utility of ferrets for incisive immunological studies is hampered by limited reagents to study ferret immunity and a paucity of background knowledge about the ferret immune system. Some insights into ferrets' immunological responses to influenza have been gained by indirect measurements of immune gene expression such as quantitative RT-PCR (qRT-PCR), transcriptome analysis or oligonucleotide microarrays. 22, [96] [97] [98] [99] [100] For example, assessing the differential expression levels of innate and adaptive immune genes in the lungs following primary or secondary 2009 H1N1pdm infection revealed upregulation of interferon-stimulated genes involved in antiviral responses such as C-X-C motif chemokine 10 (CXCL10), 2′-5′ oligoadenylate synthase 1 (OAS1), interferon regulatory factor 1 (IRF1) and radical S-adenosyl methionine domain containing 2 (RSAD2) as well as chemokines such as CXCL16 and C-C motif chemokines 3, 4 and 5 (CCL3, CCL4 and CCL5). 98 Similarly, the degree of disease severity, virus shedding and transmission in ferrets has been associated with tumour necrosis factor (TNF) and interleukin-6 (IL-6) mRNA expression in the upper respiratory tract. 97 However, mRNA levels can correlate poorly with protein levels, 101 and techniques such as flow cytometry, bead arrays and immunohistochemistry would facilitate direct measurement of immune marker expression. To date, flow cytometric or microscopy techniques have been limited in ferrets by the lack of suitable antibodies specific for ferret immune cell markers. Screening for cross-species reactivity has identified antibody clones recognising ferret T-cell markers such as CD3 and CD8, and an intracellular B-cell marker CD79b 102-104 (summarised in Table 1 ). The utility of such cross-reactive reagents has been shown experimentally. For example, prime-boost immunisation using DNA and adenoviral-based influenza vaccines provided effective protection in experimentally challenged ferrets, with protection correlating to the capacity of CD3+ T cells to express interferon gamma (IFN-γ) following in vitro stimulation on peripheral blood mononuclear cells (PBMCs) with HA peptide pools. 92 Caution should be taken when using antibodies developed for other species in ferret experiments, as there may be subsets of cells displaying variable reactivity to the antibodies. 105, 106 In addition, currently available anti-ferret B-cell antibodies such as CD79α target intracellular epitopes, requiring fixation and permeabilisation. This limits downstream applications such as RT-PCR or the recovery of antigen-specific immunoglobulin sequences from sorted B cells. In the absence of cross-reactive clones, several groups have generated novel monoclonal antibodies specific for ferret cellular markers. For example, novel antiferret CD4-, CD8-and CD5-specific antibodies were derived by 109 and are reviewed in detail further below. Using existing reagents, innate and adaptive immune responses to influenza infection 52,108,110 and immunisation 83, 111 have been studied and provide important insights into ferret antiviral immunity. In addition to influenza, the ferret serves as a critical model for with mortality rates of up to 10%. 135 However, leucocyte counts and interferon-related gene expression were decreased upon re-infection, 5 suggesting that innate immune dysregulation is a possible mechanism of pathogenesis, though a protective antibody response was also evident during attempts to re-infect ferrets. 8 Emerging viruses belonging to the Paramyxoviridae family (Henipaviruses) can cause severe respiratory illness and/or encephalitis in humans. Ferrets infected with henipaviruses exhibit similar symptoms as humans including respiratory signs such as cough and nasal discharge, neural signs such as depression, 32 and high mortality rates with most experimentally infected ferrets succumbing within 1 week. 31 While the virus is detected in pharyngeal and rectal secretions, it is currently unclear if ferrets could serve as a transmission model for the disease. 31, 32 Ferrets infected intranasally with henipaviruses similarly display clinical illness. 31, 34 Assessment of immune gene expression by Leon et al 31 in both lungs and brain tissues of the infected ferrets revealed upregulation of macrophage markers such as CD40 and CD80 in both lung and brain tissues, whereas lymphocytic markers were unchanged in the lungs. Filoviridae family of viruses. 28 Ferrets display hallmarks of pathological processes of human lethal infections such as petechial rashes, reticulated pallor of the liver and splenomegaly. 23, 24 Transmission has also been reported in ferrets. 141 As for immunological studies, transcriptomic sequencing in ferrets While the ferret model has unique potential for informative studies into pathogenic viral infections as noted above, addressing several key knowledge gaps will substantially advance the ferret as an immunological model. There is a lack of well-annotated, ferret genomic sequence infor- Future development of markers to delineate more T-cell subsets will increase the utility of the ferret as an immunological model; a recent report listed several important ferret T cell-specific antibodies to be in production at the CEIRS such as CD4, CCR7 , CD3e, CD40, CD40L, CD44, CD62L, CD69, CD103, PD-1, CXCR3, CXCR5, IL-7R and IL-15R. 109 To increase our understanding of antibody responses in ferrets, flow cytometric reagents that are able to delineate B-cell subsets are required. Important ferret B cell-specific antibodies that are in production at the CEIRS include CD83, CD86, CD95, CD19, CD20, CD25, CD27, CD38, CD138 and FcR. 109 Several markers defining innate cell populations in mice and humans such as CD11b 103,108 and CD14 102 have also been reported to cross-react with ferret leucocytes and have been utilised to characterise ferret innate immune responses. However, these markers have also been found to be expressed in non-myeloid lineages in humans, 150, 151 and other markers such as CD16 152 and CD66 153 will be required to better define myeloid cell populations. Ferret immunoglobulin subclass and Fc receptors are not well studied. Currently, only one IgG subclass that has been identified in ferrets, while four different IgG subclasses have been identified in other carnivores such as dogs 154 and minks 155 163 While a ferret-specific T-cell IFN-γ expression assays 164 to measure CD8 T-lymphocyte activation have been developed and validated, the future elucidation of corresponding antibody/Fc receptor ferret orthologues will enable ferrets to be used to evaluate ADCC responses. Epitope mapping studies using either human or murine monoclonal antibodies have greatly increased our understanding of influenza viral evolution and allowed the identification of major Ferrets have tremendous utility for studying the pathogenesis and transmission of several human respiratory diseases and for pre-clinical evaluation of vaccines. Ferrets are a critically important model that directly impacts human seasonal influenza vaccine selection and the pre-clinical development of vaccines for other emerging diseases. However, knowledge gaps limit the in-depth assessment of any immune mechanisms that may underpin transmission, protection and/immunopathology of these viral diseases in the ferret model. There is an urgent need for novel reagents with well-validated and specific targets to resolve different immune cell populations. Improving the ferret model to enable the application of insightful modern immunological tools, such as single-cell B-cell receptor sequencing, next-generation sequencing platforms and other bioinformatics tools, will greatly enhance the informative value of the ferret model which will in turn lead to better immunological interventions for human respiratory diseases. This work was supported by NHMRC programme grant #1052979 (SJK) and NHMRC project grant #1129099 (AKW). JW is supported by a Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. JW performed literature review and prepared the manuscript. DL, SK and AW edited and provided comments. All authors contributed to the formulation of this scientific research topic. Julius Wong https://orcid.org/0000-0003-0253-6151 Adam K. Wheatley https://orcid.org/0000-0002-5593-9387 Stephen J. Kent https://orcid.org/0000-0002-8539-4891 Comparative primate genomics: emerging patterns of genome content and dynamics Roest Crollius H. Human and non-human primate genomes share hotspots of positive selection Genetic diversity in humans and non-human primates and its evolutionary consequences The mouse genome Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models The SARS-CoV ferret model in an infection-challenge study Pathology of experimental SARS coronavirus infection in cats and ferrets The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination SARS-CoV regulates immune function-related gene expression in human monocytic cells Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets Ferrets as a novel animal model for studying human respiratory syncytial virus infections in immunocompetent and immunocompromised hosts Animal models of respiratory syncytial virus infection The pathogenesis of respiratory syncytial virus infection in infant ferrets Transmission of human respiratory syncytial virus in the immunocompromised ferret Experimental infection with respiratory syncytial virus in several species of animals Pathogenesis, humoral immune responses and transmission between co-housed animals in a ferret model of human RSV infection Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design Characterization of the localized immune response in the respiratory tract of ferrets following infection with influenza A and B viruses Ferrets infected with Bundibugyo virus or Ebola virus recapitulate important aspects of human filovirus disease The domestic ferret (Mustela putorius furo) as a lethal infection model for 3 species of Ebolavirus Antibodies from a human survivor define sites of vulnerability for broad protection against Ebolaviruses Chimeric antibodies with extended half-life in ferrets. Influenza Other Respir Viruses Comparative phylogeography of African fruit bats (Chiroptera, Pteropodidae) provide new insights into the outbreak of Ebola virus disease in West Africa Discussions and decisions of the 2012-2014 international committee on taxonomy of viruses (ICTV) Filoviridae Study Group Hendra vaccine success announced A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains Animal challenge models of henipavirus infection and pathogenesis Bacterial infections in pigs experimentally infected with Nipah virus Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months Time lines of infection and disease in human influenza: a review of volunteer challenge studies Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors Ferret respiratory system: clinical anatomy, physiology, and disease Influenza virus receptors in the human airway Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals Animal models in influenza research Pathogenesis of avian influenza A (H5N1) viruses in ferrets Complexities in ferret influenza virus pathogenesis and transmission models Mapping influenza transmission in the ferret model to transmission in humans Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance Severity of pneumonia due to New H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic H3N2 influenza viruses in humans: viral mechanisms, evolution, and evaluation Fatal myopericarditis following an influenza A (H3N2) infection Clinical and epidemiological features in H1N1 and H3N2 influenza A virus. 10.1 Respiratory Infections Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume Identification of lowand high-impact hemagglutinin amino acid substitutions that drive antigenic drift of influenza A(H1N1) viruses Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease Vaccines for preventing influenza in the elderly Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus Influenza vaccine effectiveness against pediatric deaths Influenza vaccine effectiveness and uptake in children at risk of severe disease Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza Mismatching between circulating strains and vaccine strains of influenza: effect on Hajj pilgrims from both hemispheres Optimizing the impact of low-efficacy influenza vaccines Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US Towards a universal influenza vaccine: different approaches for one goal Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets Hemagglutininstem nanoparticles generate heterosubtypic influenza protection Sequential immunization with live-attenuated chimeric hemagglutinin-based vaccines confers heterosubtypic immunity against influenza A viruses in a preclinical ferret model Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model Synthetic long peptide influenza vaccine containing conserved T and B cell epitopes reduces viral load in lungs of mice and ferrets Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets Comparison of heterosubtypic protection in ferrets and pigs induced by a single-cycle influenza vaccine Generation of influenza A viruses as live but replication-incompetent virus vaccines Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine Generation of a live attenuated influenza vaccine that elicits broad protection in mice and ferrets Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets Seasonal influenza split vaccines confer partial cross-protection against heterologous influenza virus in ferrets when combined with the CAF01 adjuvant Poly-gamma-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation Oseltamivir prophylaxis reduces inflammation and facilitates establishment of crossstrain protective T cell memory to influenza viruses Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets Local innate immune responses and influenza virus transmission and virulence in ferrets Sequencing, annotation, and characterization of the influenza ferret infectome Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses Correlation of mRNA and protein in complex biological samples Characterization of antibodies against ferret immunoglobulins, cytokines and CD markers Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model Cross-reactivity of monoclonal antibodies on peripheral blood cells from common marmosets by flow cytometry Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules Development of an anti-ferret CD4 monoclonal antibody for the characterisation of ferret T lymphocytes Flow cytometric and cytokine ELISpot approaches to characterize the cell-mediated immune response in ferrets following influenza virus infection Moving forward: recent developments for the ferret biomedical research model. mBio Peripheral leukocyte migration in ferrets in response to infection with seasonal influenza virus Influenza vaccination accelerates recovery of ferrets from lymphopenia Transmission of a 2009 H1N1 pandemic influenza virus occurs before fever is detected, in the ferret model Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets Analyses of cellular immune responses in ferrets following influenza virus infection The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity Understanding and manipulating viral immunity: antibody immunodominance enters center stage Immune system cells in healthy ferrets Infection of ferrets with influenza virus elicits a light chain-biased antibody response against hemagglutinin Host immune response to influenza A virus infection Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination A simple flow-cytometric method measuring B cell surface immunoglobulin avidity enables characterization of affinity maturation to influenza A virus Defining B cell immunodominance to viruses Antibody immunodominance: the key to understanding influenza virus antigenic drift A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies Potential role of Fc-receptor functions in the development of a universal influenza vaccine. Vaccines (Basel) Viral interference: the case of influenza viruses Evidence for viral interference and cross-reactive protective immunity between influenza B virus lineages Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections. Influenza Other Respir Viruses C-C motif chemokine ligand 2 (CCL2) mediates acute lung injury induced by lethal influenza H7N9 virus Role of NK cells in influenza infection Dendritic cells and influenza A virus infection The role of neutrophils during mild and severe influenza virus infections of mice Influenza virus replication in macrophages: balancing protection and pathogenesis Recalling the future: immunological memory toward unpredictable influenza viruses Severe acute respiratory distress syndrome (SARS): a critical care perspective Virology: SARS virus infection of cats and ferrets Animal models and vaccines for SARS-CoV infection Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques Viral and host factors in human respiratory syncytial virus pathogenesis Modeling Ebola virus transmission using ferrets. mSphere Comparative transcriptomics in Ebola Makona-infected ferrets, nonhuman primates, and humans The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication Genome sequence, comparative analysis and haplotype structure of the domestic dog IMGT(R), the international ImMunoGeneTics information system(R) 25 years on A model of somatic hypermutation targeting in mice based on high-throughput Ig sequencing data Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning Soluble T-cell receptors produced in human cells for targeted delivery Time to abandon dogma: CD14 is expressed by nonmyeloid lineage cells Flow cytometric analysis of inflammatory and resident myeloid populations in mouse ocular inflammatory models CD16+ and CD16− human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells CD66: role in the regulation of neutrophil effector function Comparative functional characterization of canine IgG subclasses Immunoglobulins of mink. Evidence for five immunoglobulin classes of 7S type In Vitro functional characterization of feline IgGs Antibodydependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques Influenzaspecific antibody-dependent phagocytosis What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins Influenza virus-specific antibody dependent cellular cytotoxicity induced by vaccination or natural infection Fc functional antibodies in humans with severe H7N9 and seasonal influenza Influenza-specific antibodydependent cellular cytotoxicity: toward a universal influenza vaccine Immune system cells in healthy ferrets: an immunohistochemical study Cloning, expression and immunoassay detection of ferret IFN-gamma Antigenic maps of influenza A(H3N2) produced with human antisera obtained after primary infection Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) Isolation and characterization of human monoclonal antibodies that recognize the influenza A(H1N1)pdm09 virus hemagglutinin receptor-binding site and rarely yield escape mutant viruses Antibody responses toward the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets, and humans H3N2 mismatch of 2014-15 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains Mink infected with Aleutian disease virus have an elevated level of CD8-positive T-lymphocytes